{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:23:33Z","timestamp":1768638213983,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1023\/a:1025682410937","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T22:47:08Z","timestamp":1064357228000},"page":"609-618","source":"Crossref","is-referenced-by-count":8,"title":["Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States)"],"prefix":"10.1007","volume":"14","author":[{"given":"H.","family":"Furberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Millikan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Geradts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.G.","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5124758_CR1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev\n15: 36-47.","journal-title":"Epidemiol Rev"},{"key":"5124758_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/oxfordjournals.aje.a010275","volume":"151","author":"IJ Hall","year":"2000","unstructured":"Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol\n151: 754-764.","journal-title":"Am J Epidemiol"},{"key":"5124758_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/oxfordjournals.epirev.a036096","volume":"15","author":"DJ Hunter","year":"1993","unstructured":"Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer [Review]. Epidemiol Rev\n15: 110-132.","journal-title":"Epidemiol Rev"},{"key":"5124758_CR4","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/carcin\/17.11.2279","volume":"17","author":"HS Feigelson","year":"1996","unstructured":"Feigelson HS, Henderson BE (1996) Estrogens and breast cancer: commentary. Carcinogenesis\n17: 2279-2284.","journal-title":"Carcinogenesis"},{"key":"5124758_CR5","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Res\n50: 7415-7421.","journal-title":"Cancer Res"},{"key":"5124758_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","volume":"36","author":"JD Yager","year":"1996","unstructured":"Yager JD, Liehr JG (1996) Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharacol Toxicol\n36: 203-232.","journal-title":"Annu Rev Pharacol Toxicol"},{"issue":"3","key":"5124758_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","volume":"21","author":"BE Henderson","year":"2000","unstructured":"Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis\n21(3): 427-433.","journal-title":"Carcinogenesis"},{"key":"5124758_CR8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1126\/science.279.5357.1631","volume":"279","author":"RF Service","year":"1998","unstructured":"Service RF (1998) New role for estrogen in cancer? Science\n279: 1631-1633.","journal-title":"Science"},{"key":"5124758_CR9","volume-title":"Cancer, Principles and Practice of Oncology","author":"VT DeVita Jr","year":"1997","unstructured":"DeVita VT Jr, Hellman S, Rosenberg SA (1997) Cancer, Principles and Practice of Oncology. Philadelphia: J. P. Lippincott."},{"key":"5124758_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.aje.a113509","volume":"117","author":"NS Weiss","year":"1983","unstructured":"Weiss NS, Liff JM (1983) Accounting for the multicausal nature of disease in the design and analysis of epidemiologic studies. Am J Epidemiol\n117: 14-18.","journal-title":"Am J Epidemiol"},{"key":"5124758_CR11","first-page":"319","volume":"4","author":"JD Potter","year":"1995","unstructured":"Potter JD, Cerhan JR, Sellers TA, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev\n4: 319-326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.aje.a010265","volume":"151","author":"WY Huang","year":"2000","unstructured":"Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol\n151: 703-714.","journal-title":"Am J Epidemiol"},{"key":"5124758_CR13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/jnci\/83.20.1483","volume":"83","author":"H Olsson","year":"1991","unstructured":"Olsson H, Borg A, Ferno M, Ranstam J, Sigurdsson H (1991) HER-2\/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. J Natl Cancer Inst\n83: 1483-1487.","journal-title":"J Natl Cancer Inst"},{"key":"5124758_CR14","first-page":"413","volume":"8","author":"MD Gammon","year":"1999","unstructured":"Gammon MD, Hibshoosh H, Terry MB, et al. (1999) Oral contraceptive use and other risk factors in relation to HER-2\/neu overexpression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev\n8: 413-419.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR15","first-page":"65","volume":"9","author":"W-Y Huang","year":"2000","unstructured":"Huang W-Y, Newman B, Millikan RC, et al. (2000) Risk of breast cancer according to the status of HER-2\/neu oncogene amplification. Cancer Epidemiol Biomarkers Prev\n9: 65-71.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","volume":"9","author":"B Vogelstein","year":"1993","unstructured":"Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. TIG\n9: 138.","journal-title":"TIG"},{"issue":"Suppl2","key":"5124758_CR17","doi-asserted-by":"crossref","first-page":"SII17","DOI":"10.1016\/S0140-6736(98)90328-2","volume":"351","author":"D Lane","year":"1998","unstructured":"Lane D (1998) The promise of molecular oncology. Lancet\n351(Suppl 2): SII17-SII20.","journal-title":"Lancet"},{"key":"5124758_CR18","first-page":"4855","volume":"54","author":"MS Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res\n54: 4855-4878.","journal-title":"Cancer Res"},{"key":"5124758_CR19","first-page":"115","volume":"1","author":"CC Harris","year":"1996","unstructured":"Harris CC (1996) p53: at the crossroads of molecular carcinogenesis and molecular epidemiology. J Investig Dermatol Symp Proc\n1: 115-118.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"5124758_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/scbi.2001.0390","volume":"11","author":"M Olivier","year":"2001","unstructured":"Olivier M, Hainaut P (2001) TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis. Semin Cancer Biol\n11: 353-360.","journal-title":"Semin Cancer Biol"},{"key":"5124758_CR21","first-page":"1","volume":"2","author":"DW Yandell","year":"1993","unstructured":"Yandell DW, Thor AD (1993) p53 analysis in diagnostic pathology. Biologic implications and possible clinical applications. Diagn Mol Pathol\n2: 1-3.","journal-title":"Diagn Mol Pathol"},{"key":"5124758_CR22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijc.2910570410","volume":"57","author":"H Tsuda","year":"1994","unstructured":"Tsuda H, Hirohashi S (1994) Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int J Cancer\n57: 498-503.","journal-title":"Int J Cancer"},{"key":"5124758_CR23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/oxfordjournals.aje.a008862","volume":"144","author":"KK van der","year":"1996","unstructured":"van der KK, Rookus MA, Peterse HL, van Leeuwen FE (1996) p53 protein overexpression in relation to risk factors for breast cancer. Am J Epidemiol\n144: 924-933.","journal-title":"Am J Epidemiol"},{"key":"5124758_CR24","first-page":"255","volume":"8","author":"MD Gammon","year":"1999","unstructured":"Gammon MD, Hibshoosh H, Terry MB, et al. (1999) Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev\n8: 255-263.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00694745","volume":"35","author":"B Newman","year":"1995","unstructured":"Newman B, Moorman PG, Millikan R, et al. (1995) The Carolina breast cancer study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat\n35: 51-60.","journal-title":"Breast Cancer Res Treat"},{"key":"5124758_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00694746","volume":"35","author":"TE Aldrich","year":"1995","unstructured":"Aldrich TE, Vann D, Moorman PG, Newman B (1995) Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat\n35: 61-64.","journal-title":"Breast Cancer Res Treat"},{"key":"5124758_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.aje.a116104","volume":"134","author":"CR Weinberg","year":"1991","unstructured":"Weinberg CR, Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol\n134: 421-432.","journal-title":"Am J Epidemiol"},{"key":"5124758_CR28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1047-2797(98)00057-X","volume":"9","author":"PG Moorman","year":"1999","unstructured":"Moorman PG, Newman B, Millikan R, Tse C-KJ, Sandler DP (1999) Participation rates in a case-control study: the impact of age, race and race of interviewer. Ann Epidemiol\n9: 188-195.","journal-title":"Ann Epidemiol"},{"key":"5124758_CR29","first-page":"371","volume":"7","author":"R Millikan","year":"1998","unstructured":"Millikan R, Pittman G, Newman B, et al. (1998) Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev\n7: 371-378.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ije\/28.3.396","volume":"28","author":"H Furberg","year":"1999","unstructured":"Furberg H, Newman B, Moorman P, Millikan R (1999) Lactation and breast cancer risk. Int J Epidemiol\n28: 396-402.","journal-title":"Int J Epidemiol"},{"key":"5124758_CR31","first-page":"329","volume":"93","author":"PG Moorman","year":"2001","unstructured":"Moorman PG, Millikan RC, Newman B (2001) Oral contraceptives and breast cancer among African-American women and white women. J Natl Med Assoc\n93: 329-334.","journal-title":"J Natl Med Assoc"},{"key":"5124758_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1006354627669","volume":"58","author":"LG Dressler","year":"1999","unstructured":"Dressler LG, Geradts J, Burroughs M, Cowan D, Millikan RC, Newman B (1999) Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: the UNC SPORE experience. University of North Carolina Specialized Program of Research Excellence. Breast Cancer Res Treat\n58: 31-39.","journal-title":"Breast Cancer Res Treat"},{"key":"5124758_CR33","volume-title":"SAS\/STAT User's Guide","author":"Sas Institute Inc.","year":"1988","unstructured":"Sas Institute Inc. (1988) SAS\/STAT User's Guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc.","edition":"Release 6.03 Ed"},{"key":"5124758_CR34","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2436::AID-CNCR35>3.0.CO;2-#","volume":"86","author":"JW Yarbro","year":"1999","unstructured":"Yarbro JW, Page DL, Fielding LP, Partridge EE, Murphy GP (1999) American Joint Committee on Cancer prognostic factors consensus conference. Cancer\n86: 2436-2446.","journal-title":"Cancer"},{"key":"5124758_CR35","first-page":"173","volume":"3","author":"CB Begg","year":"1994","unstructured":"Begg CB, Zhang ZF (1994) Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev\n3: 173-175.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR36","first-page":"829","volume":"11","author":"H Furberg","year":"2002","unstructured":"Furberg H, Millikan RC, Geradts J, et al. (2002) Environmental exposures in relation to breast cancer characterized by p53 expression. Cancer Epidemiol Biomarkers Prev\n11: 829-835.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5124758_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/carcin\/17.1.145","volume":"17","author":"VM De Benedetti","year":"1996","unstructured":"De Benedetti VM, Welsh JA, Yu MC, Bennett WP (1996) p53 mutations in hepatocellular carcinoma related to oral contraceptive use. Carcinogenesis\n17: 145-149.","journal-title":"Carcinogenesis"},{"key":"5124758_CR38","first-page":"2011","volume":"59","author":"JE Armes","year":"1999","unstructured":"Armes JE, Trute L, White D, et al. (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res\n59: 2011-2017.","journal-title":"Cancer Res"},{"key":"5124758_CR39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(05)63327-2","volume":"350","author":"T Crook","year":"1997","unstructured":"Crook T, Crossland S, Crompton MR, Osin P, Gusterson BA (1997) p53 mutations in BRCA1-associated familial breast cancer. Lancet\n350: 638-639.","journal-title":"Lancet"},{"key":"5124758_CR40","first-page":"3703","volume":"54","author":"OK Glebov","year":"1994","unstructured":"Glebov OK, McKenzie KE, White CA, Sukumar S (1994) Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res\n54: 3703-3709.","journal-title":"Cancer Res"},{"key":"5124758_CR41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.1991.03470050081027","volume":"266","author":"PG Shields","year":"1991","unstructured":"Shields PG, Harris CC (1991) Molecular epidemiology and the genetics of environmental cancer. JAMA\n266: 681-687.","journal-title":"JAMA"},{"key":"5124758_CR42","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1200\/JCO.2000.18.24.4045","volume":"18","author":"PO Chappuis","year":"2000","unstructured":"Chappuis PO, Kapusta L, Begin LR, et al. (2000) Germline BRCA1\/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. J Clin Oncol\n18: 4045-4052.","journal-title":"J Clin Oncol"},{"key":"5124758_CR43","first-page":"4092","volume":"61","author":"MS Greenblatt","year":"2001","unstructured":"Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res\n61: 4092-4097.","journal-title":"Cancer Res"},{"key":"5124758_CR44","doi-asserted-by":"crossref","first-page":"18808","DOI":"10.1074\/jbc.274.26.18808","volume":"274","author":"DW Abbott","year":"1999","unstructured":"Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT (1999) BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem\n274: 18808-18812.","journal-title":"J Biol Chem"},{"key":"5124758_CR45","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0140-6736(92)90866-2","volume":"339","author":"KH Vahakangas","year":"1992","unstructured":"Vahakangas KH, Samet JM, Metcalf RA, et al. (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet\n339: 576-580.","journal-title":"Lancet"},{"key":"5124758_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1006163101948","volume":"52","author":"RM Elledge","year":"1998","unstructured":"Elledge RM, Allred DC (1998) Prognostic and predictive value of p53 and p21 in breast cancer. Breast Cancer Res Treat\n52: 79-98.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025682410937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025682410937\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025682410937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:00:08Z","timestamp":1750960808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025682410937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["5124758"],"URL":"https:\/\/doi.org\/10.1023\/a:1025682410937","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}